Hims vs Sequence
A detailed head-to-head comparison of Hims and Sequence — pricing, peptides, consultation models, and patient reviews.
At a Glance
Rating★★★★☆ 4.0/5
Starting Price$199/mo
Peptides2
ConsultationAsync Telehealth
Lab TestingNo
Shipping3-5 business days
Pros
- Publicly traded company with financial transparency
- Massive scale — millions of customers across health verticals
- Both compounded and brand-name options
- Free provider consultations included
Cons
- No video consultations
- No lab testing included
- GLP-1 only — no other peptides
- Compounded medication availability may vary by state
RatingNo reviews
Starting PriceN/A
Peptides2
ConsultationHybrid
Lab TestingNo
Shipping3-5 business days
Pros
- Founded by obesity medicine specialists
- Insurance-first approach can save patients hundreds per month on brand-name GLP-1 medications
- Video consultations with experienced clinicians, not just questionnaire-based async reviews
- Prior authorization and insurance appeals support included in membership
- Personalized titration managed through follow-up video visits
Cons
- Higher total cost for cash-pay patients
- The $99/month membership is charged on top of medication costs (unlike all-inclusive platforms)
- No published independent outcomes data for their patient population
- Insurance navigation success varies
- Less established brand than Hims or Ro
Pros & Cons
Peptide Pricing Comparison
| Peptide | Hims | Sequence |
|---|---|---|
| Semaglutide | $199/monthly | Price unavailable |
| Tirzepatide | $399/monthly | Price unavailable |
Frequently Asked Questions
Is Hims or Sequence better?
Hims offers 2 peptides with a 4/5 rating and async telehealth consultations. Sequence offers 2 peptides and hybrid consultations. The best choice depends on which peptides you need, your budget, and preferred consultation model.
Which is cheaper, Hims or Sequence?
See the pricing table above for a detailed comparison.